fusokine

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namefusokine

Drug Alias NameL-2/IL-18 fusion protein (Transgene)cytokine therapy (Transgene)IL-2/IL-18 fusion protein (Ad-5) (Transgene)IL-2/IL-18 fusion protein (Transgene)

ClassificationBiologics

Mechanisms of ActionInterleukin 18 stimulantsIL2 gene transference

TargetsInterleukin-2Interleukin 18

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTransgene Sa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTransgene Sa

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A